1032289-55-6 Usage
General Description
4-(2,5-DIMETHYL-PYRROL-1-YL)-PIPERIDINE, also known as 2,5-dimethyl-1-(4-piperidinyl)cyclopentanone, is a chemical compound commonly used in the field of pharmaceutical research and development. It is a piperidine derivative with a pyrrole ring, and its chemical structure is composed of a piperidine ring attached to a 2,5-dimethylpyrrole moiety. 4-(2,5-DIMETHYL-PYRROL-1-YL)-PIPERIDINE has shown potential in various medicinal applications, primarily as a building block for the synthesis of biologically active compounds. It is also commonly used as a ligand in coordination chemistry and as an intermediate in the production of pharmaceuticals. Additionally, it has been identified as a useful reagent in the synthesis of various heterocyclic compounds and natural products. Overall, 4-(2,5-DIMETHYL-PYRROL-1-YL)-PIPERIDINE is a versatile chemical with diverse applications in the pharmaceutical industry and chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 1032289-55-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,2,2,8 and 9 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1032289-55:
(9*1)+(8*0)+(7*3)+(6*2)+(5*2)+(4*8)+(3*9)+(2*5)+(1*5)=126
126 % 10 = 6
So 1032289-55-6 is a valid CAS Registry Number.
1032289-55-6Relevant articles and documents
Convenient strecker reactions of piperidine derivatives with cyclic ketones under aqueous conditions
Murata, Yoshinori,Satake, Kunio
, p. 1485 - 1490 (2008)
Strecker reactions convenient for the preparation of piperidinyl acetonitrile compounds under aqueous conditions are described. The use of TsOH·H2O is the key to afford the desired products in good and reproducible yield. Copyright Taylor & Francis Group,
Novel non-peptide nociceptin/orphanin FQ receptor agonist, 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl] -1H-benzimidazole: Design, synthesis, and structure-activity relationship of oral receptor occupancy in the brain for orally potent
Hayashi, Shigeo,Hirao, Akiko,Imai, Aki,Nakamura, Hiroshi,Murata, Yoshinori,Ohashi, Katsuyo,Nakata, Eriko
experimental part, p. 610 - 625 (2009/12/29)
An endogenous heptadecapeptide, nociceptin/orphanin FQ (N/OFQ), and a G-protein-coupled receptor, N/OFQ peptide (NOP) receptor [or opioid-receptor-like-1 (ORL1) receptor], have been described in terms of its structure, distribution, and pharmacology. Thus
